NCT06942871Completed
Non-Invasive Lung Water Monitoring in Pulmonary Hypertension
Non-Invasive Lung Water Monitoring Guided by Remote Dielectric Sensing Technology in the Management of Patients With Pulmonary Hypertension
Source: ClinicalTrials.gov · Last updated 29 Apr 2025
Brief summary (registry, in English)
The investigators conducted a prospective, convenience-sampled observational pilot study, enrolling adult patients with pulmonary hypertension who were either outpatients or inpatients in the cardiology department of our hospital. The measurement of Remote Dielectric Sensing (ReDS) values was performed by ReDS™ Pro. Data were collected using the electronic medical record system of our hospital. Participants were followed up within 6 months after discharge. The primary endpoints included all-cause mortality or clinical deterioration related to pulmonary hypertension.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 202 (actual)
- First submitted
- 17 Apr 2025
- Start date
- 1 Apr 2024
- Primary completion date
- 5 Mar 2025
- Lead sponsor
- Shanghai Zhongshan Hospital
- NCT number
- NCT06942871
What you commit to
- Study type: Observational
- Participants enrolled: 202
- From 1 Apr 2024 to the primary completion date, 5 Mar 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prior implantation of a left ventricular assist device or cardiac transplantation;
Other illness
- Congenital cardiac anomalies or intrathoracic masses affecting right lung anatomy;
Other
- Thoracic deformities or injuries precluding proper device fit (e.g., severe scoliosis, flail chest);
- Inability to use the ReDS™ Pro non-invasive lung fluid monitor due to physical characteristics (height \<155 cm or \>190 cm; body mass index \[BMI\] \<22 kg/m² or \>39 kg/m²);
- Hemodynamic profiles inconsistent with PH.
Who the study is looking for
- Age ≥18 and ≤85 years, with no gender restriction;
- Hemodynamic confirmation of PH via right heart catheterization (RHC) (mean pulmonary arterial pressure \[mPAP\] \> 20 mmHg).
Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| 180 Fenglin Road Coordinator of this site? Confirm its status | Shanghai | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.